These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 9850147)
1. Early postischemic dantrolene-induced amelioration of poly(ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices. Tasker RC; Sahota SK; Cotter FE; Williams SR J Cereb Blood Flow Metab; 1998 Dec; 18(12):1346-56. PubMed ID: 9850147 [TBL] [Abstract][Full Text] [Related]
2. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645 [TBL] [Abstract][Full Text] [Related]
3. Hypercarbia and mild hypothermia, only when not combined, improve postischemic bioenergetic recovery in neonatal rat brain slices. Tasker RC; Sahota SK; Williams SR J Cereb Blood Flow Metab; 2000 Mar; 20(3):612-9. PubMed ID: 10724125 [TBL] [Abstract][Full Text] [Related]
4. Bioenergetic recovery following ischemia in brain slices studied by 31P-NMR spectroscopy: differential age effect of depolarization mediated by endogenous nitric oxide. Tasker RC; Sahota SK; Williams SR J Cereb Blood Flow Metab; 1996 Jan; 16(1):125-33. PubMed ID: 8530545 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540 [TBL] [Abstract][Full Text] [Related]
6. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase]. Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263 [TBL] [Abstract][Full Text] [Related]
7. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. Koedel U; Winkler F; Angele B; Fontana A; Pfister HW J Cereb Blood Flow Metab; 2002 Jan; 22(1):39-49. PubMed ID: 11807392 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503 [TBL] [Abstract][Full Text] [Related]
9. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects. Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650 [TBL] [Abstract][Full Text] [Related]
10. Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat. Joly LM; Benjelloun N; Plotkine M; Charriaut-Marlangue C Pediatr Res; 2003 May; 53(5):776-82. PubMed ID: 12621128 [TBL] [Abstract][Full Text] [Related]
11. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation. Kaundal RK; Shah KK; Sharma SS Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310 [TBL] [Abstract][Full Text] [Related]
13. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862 [TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447 [TBL] [Abstract][Full Text] [Related]
15. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors. Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668 [TBL] [Abstract][Full Text] [Related]
16. Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart. Nishizawa K; Yanagida S; Yamagishi T; Takayama E; Bessho M; Kusuhara M; Adachi T; Ohsuzu F J Cardiovasc Pharmacol; 2013 Jul; 62(1):99-105. PubMed ID: 23846805 [TBL] [Abstract][Full Text] [Related]
17. Adenine nucleotide metabolism and cell fate after oxidant exposure of rat cortical neurons: effects of inhibition of poly(ADP-ribose) polymerase. Aito H; Aalto KT; Raivio KO Brain Res; 2004 Jul; 1013(1):117-24. PubMed ID: 15196974 [TBL] [Abstract][Full Text] [Related]
18. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. Hagberg H; Wilson MA; Matsushita H; Zhu C; Lange M; Gustavsson M; Poitras MF; Dawson TM; Dawson VL; Northington F; Johnston MV J Neurochem; 2004 Sep; 90(5):1068-75. PubMed ID: 15312162 [TBL] [Abstract][Full Text] [Related]
19. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035 [TBL] [Abstract][Full Text] [Related]
20. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]